Last reviewed · How we verify
PrimePro
At a glance
| Generic name | PrimePro |
|---|---|
| Sponsor | Thomas Advanced Medical LLC |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions (PHASE1, PHASE2)
- Mesenchymal Stem Cells for the Treatment of COVID-19 (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- PrimePro CI brief — competitive landscape report
- PrimePro updates RSS · CI watch RSS
- Thomas Advanced Medical LLC portfolio CI